1. 1. Tabah A, Koulenti D, Laupland K, et al. Characteristics and
determinants of outcome of hospital-acquired bloodstream
infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care. Med. 2012; 38(12): 1930-45.
[CrossRef]
2. 2. Puig-Asensio M, Padilla B, Garnacho-Montero J, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in
Spain. Clin Microbiol Infect. 2014; 20(4): O245-54. [CrossRef]
3. 3. Baykara N, Akalın H, Arslantaş MK, et al. Epidemiology of sepsis
in intensive care units in Turkey: a multicenter, point-prevalence
study. Crit Care. 2018; 22(1): 93. [CrossRef]
4. 4. Colombo AL, Guimaraes T, Sukienik T, et al. Prognostic factors
and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med. 2014;
40(10): 1489-98. [CrossRef]
5. 5. Kett DK, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators.
Candida bloodstream infections in intensive care units: analysis
of the extended prevalence of infection in intensive care unit
study. Crit Care Med. 2011; 39(4): 665-7. [CrossRef]